Universitätsklinikum Tübingen

Long-term results of teduglutide treatment for chronic intestinal failure – Insights from a national, multi-centric patient home-care service program (2022) Greif S, Maasberg S, Wehkamp J, Fusco S, Zopf Y, Herrmann HJ, Lamprecht G, et al. Journal article, Original article A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy (2022) Buettner FA, Winter S, Stuehler V, Rausch S, Hennenlotter J, Füssel S, Zastrow S, et al. Journal article Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort (2022) Maghnie M, Ranke MB, Geffner ME, Vlachopapadopoulou E, Ibanez L, Carlsson M, Cutfield W, et al. Journal article Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database (2022) Iudici M, Mongin D, Siegert E, Carreira PE, Distler J, Henes J, Zanatta E, et al. Journal article Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial (2022) Eichinger A, Poetschger U, Glogova E, Bader P, Basu O, Beier R, Burkhardt B, et al. Journal article 3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) - Data from the RELIANCE Registry (2022) Kuemmerle-Deschner JB, Kortus-Goetze B, Oommen PT, Janda A, Rech J, Schuetz C, Kallinich T, et al. Conference contribution When to treat the pelvis in node-positive vulvar cancer: Results from the AGO-VOP.2 QS vulva study (2022) Hampl M, Jaeger A, Eulenburg C, Prieske K, Hambrecht J, Fuerst S, Klapdor R, et al. Conference contribution EARLY MANIFESTATION AND RAPID SYMPTOM PROGRESSION IN A CASE OF HOMOZYGOUS TRINUCLEOTIDE EXPANSION IN THE TBP-GENE IN AUTOSOMAL DOMINANT SPINOCEREBELLAR ATAXIA TYPE 17 (2022) Forras PV, Wilfling S, Mrochen A, Dufke C, Linker R, Hehr U, Kohl Z Conference contribution A randomized phase II trial of ipilimumab and nivolumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNNIFORECAST) (2022) Ahrens M, Escudier B, Haanen J, Gross-Goupil M, Boleti E, Gravis G, Grimm MO, et al. Conference contribution Factors associated with long-term survival after failure a chimeric antigen receptor (CAR) T cell therapy for relapsed or refractory large B-cell lymphomas:a role for allogeneic stem cell transplantation? (2022) Derigs P, Bethge W, Holtick U, Von Tresckow B, Ayuk F, Penack O, Vucinic V, et al. Conference contribution